Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

April 1, 2025

Study Completion Date

May 1, 2025

Conditions
Leukemia, Lymphoblastic
Interventions
DIETARY_SUPPLEMENT

enteral or parenteral nutritional support

Parents will be classified based on whether they received enteral or parenteral nutritional support during treatment.

Trial Locations (1)

54500

CHRU Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT06110182 - Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter